Trellus Health plc
TRLHF
$0.02
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 490.00% | 490.00% | 1,180.00% | 1,180.00% | 257.14% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 490.00% | 490.00% | 1,180.00% | 1,180.00% | 257.14% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 490.00% | 490.00% | 1,180.00% | 1,180.00% | 257.14% |
| SG&A Expenses | -19.35% | -19.35% | 49.76% | 49.76% | 9.06% |
| Depreciation & Amortization | -- | -- | 23.27% | 23.27% | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -19.35% | -19.35% | 43.26% | 43.26% | 9.06% |
| Operating Income | 25.63% | 25.63% | -41.24% | -41.24% | -8.14% |
| Income Before Tax | 22.98% | 22.98% | -40.37% | -40.37% | -9.08% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 22.98% | 22.98% | -40.37% | -40.37% | -9.08% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 22.98% | 22.98% | -40.37% | -40.37% | -9.08% |
| EBIT | 25.63% | 25.63% | -41.24% | -41.24% | -8.14% |
| EBITDA | 25.71% | 25.71% | -41.75% | -41.75% | -8.21% |
| EPS Basic | 22.50% | 22.50% | -39.53% | -39.53% | -9.09% |
| Normalized Basic EPS | 22.67% | 22.67% | -53.06% | -53.06% | -8.70% |
| EPS Diluted | 22.50% | 22.50% | -39.53% | -39.53% | -9.09% |
| Normalized Diluted EPS | 22.67% | 22.67% | -53.06% | -53.06% | -8.70% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |